Risk Factors Associated with Kidney Injury and the Impact of Kidney Injury on Overall Survival in Pediatric Recipients Following Allogeneic Stem Cell Transplant

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 10, 2011, Pages 1472-1480

  Satwani, Prakash ^a   Bavishi, Sejal ^a   Jin, Zhezhen ^a   Jacobson, Judith S ^b   Baker, Courtney ^a   Duffy, Deirdre ^a   Lowe, Leora ^a   Morris, Erin ^a   Cairo, Mitchell S ^a,c  

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

^c Department of Medicine   (United States)

Author keywords

Allogeneic stem cell transplant; Kidney injury; Pediatrics; Reduced toxicity and myeloablative conditioning

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B; BUSULFAN; CREATININE; CYCLOPHOSPHAMIDE; FLUDARABINE; FOSCARNET; GANCICLOVIR; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SULFAMETHOXAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIMETHOPRIM;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; FEMALE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HODGKIN DISEASE; HUMAN; HUMAN CELL; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; MYELOABLATIVE CONDITIONING; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PNEUMOCYSTOSIS; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; MYCOPHENOLIC ACID; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TACROLIMUS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052969225     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.02.006     Document Type: Article

References (35)

1. Thomas E.D. Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases. J Clin Oncol 1983, 1:517-531.
2. Satwani P., Harrison L., Morris E., Del Toro G., Cairo M.S. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges. Biol Blood Marrow Transplant 2005, 11:403-422.
3. Kist-van Holthe J.E., Goedvolk C.A., Brand R., et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002, 17:1032-1037.
4. Kist-van Holthe J.E., van Zwet J.M., Brand R., van Weel M.H., Vossen J.M., van der Heijden A.J. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998, 22:559-564.
5. Van Why S.K., Friedman A.L., Wei L.J., Hong R. Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 1991, 7:383-388.
6. Tarbell N.J., Guinan E.C., Chin L., Mauch P., Weinstein H.J. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 1990, 18(Suppl 1):139-142.
7. Schrier R.W., Parikh C.R. Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation. Nephrol Dial Transplant 2005, 20:678-683.
8. Hingorani S., Guthrie K.A., Schoch G., Weiss N.S., McDonald G.B. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007, 39:223-229.
9. Cohen E.P., Piering W.F., Kabler-Babbitt C., Moulder J.E. End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 1998, 79:408-412.
10. Hoffmeister P.A., Hingorani S.R., Storer B.E., Baker K.S., Sanders J.E. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 16:515-524.
11. Bradley M.B., Satwani P., Baldinger L., et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant 2007, 40:621-631.
12. Satwani P., Baldinger L., Freedman J., et al. Incidence of viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2009, 15:1587-1595.
13. Bhatia M., Militano O., Jin Z., et al. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2010, 16:333-343.
14. Osunkwo I., Bessmertny O., Harrison L., et al. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2004, 10:246-258.
15. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
16. Waxman I.M., Militano O., Baldinger L., et al. Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. Pediatr Transplant 2009, 13:464-474.
17. Roman E., Osunkwo I., Militano O., Cooney E., van de Ven C., Cairo M.S. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Pediatr Blood Cancer 2008, 50:325-330.
18. Shereck E.B., Cooney E., van de Ven C., Della-Lotta P., Cairo M.S. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatr Blood Cancer 2007, 49:306-312.
19. Schwartz G.J., Brion L.P., Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987, 34:571-590.
20. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
21. Hahn T., Yao S., Dunford L.M., et al. A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT. Biol Blood Marrow Transplant 2009, 15:574-579.
22. Goldstein S.L. Kidney function assessment in the critically ill child: is it time to leave creatinine behind?. Crit Care 2007, 11:141.
23. Cohen E.P., Lawton C.A., Moulder J.E., Becker C.G., Ash R.C. Clinical course of late-onset bone marrow transplant nephropathy. Nephron 1993, 64:626-635.
24. Kist-van Holthe J.E., Bresters D., Ahmed-Ousenkova Y.M., et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 2005, 36:605-610.
25. Leblond V., Sutton L., Jacquiaud C., et al. Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 1995, 6:1661-1665.
26. Patzer L., Ringelmann F., Kentouche K., et al. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 2001, 27:319-327.
27. El-Mallawany N., George D., Jin Z., et al. Adenovirus (ADV) infection in pediatric allogeneic stem cell transplantation (AlloSCT) recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Biol Blood Marrow Transplant 2010, 16:S258.
28. Parikh C.R., Yarlagadda S.G., Storer B., Sorror M., Storb R., Sandmaier B. Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008, 14:309-315.
29. Flores F.X., Brophy P.D., Symons J.M., et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 2008, 23:625-630.
30. Gruss E., Bernis C., Tomas J.F., et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 1995, 15:473-479.
31. Lane P.H., Mauer S.M., Blazar B.R., Ramsay N.K., Kashtan C.E. Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 1994, 13:613-617.
32. Sutherland S.M., Zappitelli M., Alexander S.R., et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 2010, 55:316-325.
33. Lopes J.A., Jorge S., Goncalves S., et al. Contemporary analysis of the influence of acute kidney injury (AKI) after myeloablative hematopoietic cell transplantation on long-term patient's survival. Bone Marrow Transplant 2008, 42:139-141.
34. Kersting S., Dorp S.V., Theobald M., Verdonck L.F. Acute renal failure after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 2008, 14:125-131.
35. Parikh C.R., McSweeney P., Schrier R.W. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 2005, 67:1999-2005.